Members Trust’s Labcorp LH Stock Holding History

Members Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-861	Closed	-$233K	–	121
2021 Q4	$233K	Hold	861	–	–	0.01%	107
2021 Q3	$212K	Sell	861 -76	-8%	-$19.2K	0.01%	109
2021 Q2	$222K	Hold	937	–	–	0.01%	115
2021 Q1	$205K	Buy	+937	New	+$188K	0.01%	109

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Members Trust's LH Position: Q1 2022 in Review

Members Trust sold out of Labcorp (LH) in Q1 2022, closing a stake of 861 shares — an estimated $233K sold.

Members Trust first reported a position in LH in Q1 2021 and held it in 4 quarters. The position peaked at $233K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

Members Trust reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
Members Trust sold 861 Labcorp shares in Q1 2022, an estimated $233K.
Members Trust first reported a position in Labcorp in Q1 2021 and held it in 4 quarters.
Members Trust's Labcorp position peaked at $233K in Q4 2021.
1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Members Trust's 13F filing for Q1 2022, filed 3 Aug 2022.